Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (D (Q34555854)
scientific article
Language:
(P31) (Q13442814)
(P304) 843-846
(P407) (Q1860)
(P433) 5
(P478) 92
(P577) Tuesday, March 1, 2005
(P921) (Q194908)
(Q1427096)
(Q1231081)
(Q18556333)
(Q1164529)
(P1433) (Q326309)
(P1476) "Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (D" (language: en)
(P2093) J Atzpodien
E Schmitt
U Gertenbach
P Fornara
H Heynemann
A Maskow
M Ecke
H H Wöltjen
H Jentsch
W Wieland
T Wandert
M Reitz
German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group (DGCIN)
(P2283) (Q1231081)
(P2860) (Q34545862)
(Q34534723)
(Q34534574)
(Q28364218)
(Q40614749)
(Q40676341)
(Q40731729)
(Q44774860)
(Q53657205)
(Q73513568)
(Q72275233)
(Q71721275)
(Q77311143)
(Q25938997)
other details